Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial (vol 398, pg 1344, 2021)

被引：0
|
作者：
Felip, Enriqueta
Altorki, Nasser
Zhou, Caicun
Csoszi, Tibor
Vynnychenko, Ihor
Goloborodko, Oleksandr
Luft, Alexander
Akopov, Andrey
Martinez-Marti, Alex
Kenmotsu, Hirotsugu
Chen, Yuh-Min
Chella, Antonio
Sugawara, Shunichi
Voong, David
Wu, Fan
Yi, Jing
Deng, Yu
McCleland, Mark
Bennett, Elizabeth
Gitlitz, Barbara
Wakelee, Heather
机构：
来源：
LANCET | 2021年 / 398卷 / 10312期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1686 / 1686
页数：1
相关论文
共 50 条
  • [1] Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial
    Felip, Enriqueta
    Altorki, Nasser
    Zhou, Caicun
    Csoszi, Tibor
    Vynnychenko, Ihor
    Goloborodko, Oleksandr
    Luft, Alexander
    Akopov, Andrey
    Martinez-Marti, Alex
    Kenmotsu, Hirotsugu
    Chen, Yuh-Min
    Chella, Antonio
    Sugawara, Shunichi
    Voong, David
    Wu, Fan
    Yi, Jing
    Deng, Yu
    McCleland, Mark
    Bennett, Elizabeth
    Gitlitz, Barbara
    Wakelee, Heather
    LANCET, 2021, 398 (10308): : 1344 - 1357
  • [2] Overall survival with adjuvant atezolizumab after chemotherapy in resected stage II-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase III trial
    Felip, E.
    Altorki, N.
    Zhou, C.
    Vallieres, E.
    Martinez-Marti, A.
    Rittmeyer, A.
    Chella, A.
    Reck, M.
    Goloborodko, O.
    Huang, M.
    Belleli, R.
    McNally, V.
    Srivastava, M. K.
    Bennett, E.
    Gitlitz, B. J.
    Wakelee, H. A.
    ANNALS OF ONCOLOGY, 2023, 34 (10) : 907 - 919
  • [3] Adjuvant atezolizumab in Japanese patients with resected stage IB-IIIA non-small cell lung cancer (IMpower010)
    Kenmotsu, Hirotsugu
    Sugawara, Shunichi
    Watanabe, Yasutaka
    Saito, Haruhiro
    Okada, Morihito
    Chen-Yoshikawa, Toyofumi Fengshi
    Ohe, Yuichiro
    Nishio, Wataru
    Nakagawa, Shizuka
    Nagao, Haruka
    CANCER SCIENCE, 2022, 113 (12) : 4327 - 4338
  • [4] Adjuvant atezolizumab in Japanese patients with resected stage IB-IIIA non- mall cell lung cancer (IMpower010) (vol 113, pg 4327, 2022)
    Kenmotsu, Hirotsugu
    Sugawara, Shunichi
    Watanabe, Yasutaka
    Saito, Haruhiro
    Okada, Morihito
    Yoshikawa, Toyofumi Fengshi Chen-
    Ohe, Yuichiro
    Nishio, Wataru
    Nakagawa, Shizuka
    Nagao, Haruka
    CANCER SCIENCE, 2023, 114 (05) : 2211 - 2212
  • [5] IMpower010: results from Asian patients in a phase 3 study of adjuvant atezolizumab in resected stage IB-IIIA NSCLC
    Kenmotsu, Hirotsugu
    Zhou, Caicun
    Altorki, Nasser
    Felip, Enriqueta
    Vallieres, Eric
    Sugawara, Shunichi
    Sakai, Hiroshi
    Saito, Haruhiro
    Tao, Min
    Kawaguchi, Koji
    Liu, Yunpeng
    Yu, Chong-Jen
    Wu, Qiong
    Lin, Huang
    Wu, Fan
    Bennett, Elizabeth
    Mcnally, Virginia
    Gitlitz, Barbara
    Wakelee, Heather
    ANNALS OF ONCOLOGY, 2022, 33 : S464 - S464
  • [6] IMpower010: Primary results of a phase III global study of atezolizumab versus best supportive care after adjuvant chemotherapy in resected stage IB-IIIA non-small cell lung cancer (NSCLC).
    Wakelee, Heather A.
    Altorki, Nasser K.
    Zhou, Caicun
    Csoszi, Tibor
    Vynnychenko, Ihor O.
    Goloborodko, Oleksandr
    Luft, Alexander
    Akopov, Andrey
    Martinez-Marti, Alex
    Kenmotsu, Hirotsugu
    Chen, Yuh-Min
    Chella, Antonio
    Sugawara, Shunichi
    Gitlitz, Barbara J.
    Bennett, Elizabeth
    Wu, Fan
    Yi, Jing
    Deng, Yu
    McCleland, Mark
    Felip, Enriqueta
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [7] Safety of adjuvant atezolizumab after pneumonectomy/bilobectomy in stage II-IIIA non-small cell lung cancer in the randomized phase III IMpower010 trial
    Lee, Jay M.
    Vallieres, Eric
    Ding, Beiying
    Johnson, Ann
    Bhagwakar, Jan
    Rashidi, Sanam
    Zhu, Qian
    Gitlitz, Barbara J.
    Weksler, Benny
    Costas, Kimberly
    Altorki, Nasser
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2023, 166 (03):
  • [8] IMpower010: Sites of relapse and subsequent therapy from a phase III study of atezolizumab vs best supportive care after adjuvant chemotherapy in stage IB-IIIA NSCLC
    Felip, E.
    Vallieres, E.
    Zhou, C.
    Wakelee, H.
    Bondarenko, I.
    Sakai, H.
    Saito, H.
    Ursol, G.
    Kawaguchi, K.
    Liu, Y.
    Levchenko, E.
    Kislov, N.
    Reck, M.
    Liersch, R.
    McNally, V. A.
    Zhu, Q.
    Ding, B.
    Bennett, E.
    Gitlitz, B.
    Altorki, N. K.
    ANNALS OF ONCOLOGY, 2021, 32 : S1319 - S1319
  • [9] Adjuvant chemotherapy with or without bevacizumab in patients with resected non-small-cell lung cancer (E1505): an open-label, multicentre, randomised, phase 3 trial
    Wakelee, Heather A.
    Dahlberg, Suzanne E.
    Keller, Steven M.
    Tester, William J.
    Gandara, David R.
    Graziano, Stephen L.
    Adjei, Alex A.
    Leighl, Natasha B.
    Aisner, Seena C.
    Rothman, Jan M.
    Patel, Jyoti D.
    Sborov, Mark D.
    McDermott, Sean R.
    Perez-Soler, Roman
    Traynor, Anne M.
    Butts, Charles
    Evans, Tracey
    Shafqat, Atif
    Chapman, Andrew E.
    Kasbari, Samer S.
    Horn, Leora
    Ramalingam, Suresh S.
    Schiller, Joan H.
    LANCET ONCOLOGY, 2017, 18 (12): : 1610 - 1623
  • [10] IMpower010: Updated overall survival and safety results from Asian patients in a Phase III study of adjuvant atezolizumab vs best supportive care in resected stage IB-IIIA NSCLC
    Wang, Jie
    Fan, Yun
    Fang, Jian
    He, Jianxing
    Liu, Yunpeng
    Tao, Min
    Altorki, Nasser
    Felip, Enriqueta
    Wakelee, Heather
    Vallieres, Eric
    Belleli, Rossella
    McNally, Virginia
    Bennett, Elizabeth
    Gitlitz, Barbara J.
    Zhou, Caicun
    CANCER RESEARCH, 2024, 84 (07)
12345